Home Newsfeeds Akero Therapeutics Q2 EPS $(0.77) Up From $(0.83) YoY

Akero Therapeutics Q2 EPS $(0.77) Up From $(0.83) YoY

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.77) per share. This is a 7.23 percent increase over losses of $(0.83) per share from the same period last year.

byBenzinga Newsdesk

August 4, 2022

1 minute read

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.77) per share. This is a 7.23 percent increase over losses of $(0.83) per share from the same period last year.

News

What’s Going On With JetBlue Airways Stock

By Henry Khederian

January 13, 3:42 PM

JetBlue Airways Corporation (NASDAQ: JBLU) shares are trading marginally higher by 1.11% to $8.21 Friday afternoon after earlier trading lower in sympathy with Delta Air Lines. Delta on Friday issued first-quarter EPS guidance below estimates.

JBLU

Nasdaq Dips Over 300 Points, Volatility In Markets Increases

By Lisa Levin

September 30, 3:35 AM

U.S. stocks closed sharply lower on Thursday, as investors were worried over the Federal Reserve's aggressive policy stance, raising recession concerns for the US economy. The Down is down over 8% this month, while the S&P 500 tumbled to its lowest level last seen in November 2020.

AAPL